Literature DB >> 2777043

Geographic origins of Jewish patients with inflammatory bowel disease.

M P Roth1, G M Petersen, C McElree, E Feldman, J I Rotter.   

Abstract

Ulcerative colitis and Crohn's disease are more common among Jews than among non-Jews. Despite the existence of studies on the prevalence and incidence of inflammatory bowel disease in relation to the continent of residence or origin, there are no studies on the specific countries of origin of Ashkenazi Jewish patients. We report here the first analysis of 233 U.S. Jewish patients by defined world regions and subregions. Using two different sets of controls (a self-referred Jewish population for Tay-Sachs disease carrier detection and a sample of Jewish persons ascertained through unrelated studies from the same hospital as our patients), we found a significant excess of patients of middle European origin relative to those of Polish or Russian origin. These observations suggest that the inflammatory bowel disease gene(s) are more prevalent in the Jewish population that originated in middle Europe than in those from Poland and Russia. These results further suggest that Jewish patients with inflammatory bowel disease probably represent a nonrandom genetically predisposed subset of the Jewish population. This provides further evidence for the genetic contribution to inflammatory bowel disease in general, and to its higher risk in the Jewish population.

Entities:  

Mesh:

Year:  1989        PMID: 2777043     DOI: 10.1016/0016-5085(89)91495-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.

Authors:  C L Sutton; H Yang; Z Li; J I Rotter; S R Targan; J Braun
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

3.  Helminths and harmony.

Authors:  J V Weinstock; R Summers; D E Elliott
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

4.  Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families.

Authors:  Turgut Tukel; Adel Shalata; Daniel Present; Daniel Rachmilewitz; Lloyd Mayer; Deniera Grant; Neil Risch; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2004-03-05       Impact factor: 11.025

5.  TNFSF15 is an ethnic-specific IBD gene.

Authors:  Yoana Picornell; Ling Mei; Kent Taylor; Huiying Yang; Stephan R Targan; Jerome I Rotter
Journal:  Inflamm Bowel Dis       Date:  2007-11       Impact factor: 5.325

Review 6.  Epidemiology of inflammatory bowel disease in different ethnic and religious groups: limitations and aetiological clues.

Authors:  C S Probert; V Jayanthi; D S Rampton; J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

7.  Genetic Testing in IBD Patients.

Authors:  David T Rubin
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-05

Review 8.  Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?

Authors:  Ana I Flores; Gonzalo J Gómez-Gómez; Ángeles Masedo-González; M Pilar Martínez-Montiel
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

9.  Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews.

Authors:  H Yang; C McElree; M P Roth; F Shanahan; S R Targan; J I Rotter
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

Review 10.  Unravelling the complex genetics of inflammatory bowel disease.

Authors:  R K Russell; D C Wilson; J Satsangi
Journal:  Arch Dis Child       Date:  2004-07       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.